PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 10/18/2012 -- Cypress Semicondu (NasdaqNM:CY) is -0.86 - -7.84% from the previous close of $10.97. It traded between $10.06 - 10.97 with total traded volume of 4732551 shares. Keep a close eye on CY, as the stock has been showing unusual moves over the past weeks. At Current market price, CY has recovered +2.43% from its 52-week Low of 9.87 and has Pulled back -50.68% from its 52-week high of 20.50. Cypress Semi (NYSE: CY) released its earnings data on Thursday. The company reported $0.20 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.20. Cypress Semi’s revenue was down 23.3% compared to the same quarter last year.CY opened at 10.97 on Thursday. Cypress Semi (CY) has a 52-week low of $9.87 and a 52-week high of $20.50. The company has a market cap of $1.630 billion and a price-to-earnings ratio of 31.08.
How Should Investors React To CY Now? Check here
Select Comfort (NASDAQ:SCSS) was off its session low, but still down 10% after gapping below its 50-day line despite reporting better-than-expected Q3 results. Late Wednesday, the specialty mattress maker and retailer reported earnings that jumped 48% to 46 cents or a nickel above views. Sales rose 24% to $246.8 million, edging past views of $246.6 million. The company also raised its full-year profit forecast.SCSS announced its earnings results on Wednesday. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.41 by $0.05. Select Comfort Corp.’s revenue was up 23.6% compared to the same quarter last year.
Are these stocks a buy or sell? Let us help you decide, Check here
ImmunoCellular Therapeutics Ltd. IMUC -13.28% (NYSEAMEX:IMUC) intends to offer shares and warrants, but didn’t disclose the amount. The drug developer plans to use the proceeds for the ongoing clinical development of its brain cancer treatment and lead pipeline product, ICT-107, and for general corporate purposes. The company had 40.6 million shares outstanding as of Aug. 10. Shares slipped 15% to $2.05 premarket.IMUC 16% LOWER; intends to offer shares of its common stock and warrants in an underwritten public offering.
How Should Investors Trade IMUC Now? Click Here
Gold Resource Cor (AMEX:GORO) is very active today and traded between $16.7918 - 18.13 with total traded volume of 1367212 shares. At a current price of 17.01, GORO is -3.14 - -15.58% from the previous close of $20.15. Moreover, At Current Market Price, GORO is in distance of -18.10% from its 50-day Moving Average price of $20.7691 and -25.85% from its 200-day Moving Average price of $22.9412. GORO was downgraded by analysts at Global Hunter Securities from an accumulate rating to a neutral rating.The Company has returned over $63 million to shareholders in monthly dividends since declaring commercial production July 1, 2010 and is the first Company offering shareholders the option to convert their cash dividends into physical gold or silver.
Will GORO Shareholders Sell on Bad Sector News? Free Sign Up Here
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)